ExodusPoint Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

ExodusPoint Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-150,670	Closed	-$3.77M	–	1946
2025 Q4	$3.77M	Buy	+150,670	New	+$2.68M	0.03%	576
2025 Q3	–	Sell	-58,980	Closed	-$251K	–	1880
2025 Q2	$251K	Buy	+58,980	New	+$263K	﹤0.01%	1276
2025 Q1	–	Sell	-91,298	Closed	-$532K	–	1846
2024 Q4	$532K	Buy	91,298 +21,457	+31%	+$214K	﹤0.01%	1137
2024 Q3	$834K	Buy	+69,841	New	+$893K	0.01%	1023
2022 Q1	–	Sell	-30,677	Closed	-$287K	–	2547
2021 Q4	$287K	Buy	+30,677	New	+$636K	﹤0.01%	1676
2021 Q1	–	Sell	-21,629	Closed	-$1.04M	–	2465
2020 Q4	$1.04M	Buy	+21,629	New	+$1.01M	0.01%	841

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

ExodusPoint Capital Management's OLMA Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 150,670 shares — an estimated $3.77M sold.

ExodusPoint Capital Management first reported a position in OLMA in Q4 2020 and held it in 6 quarters. The position peaked at $3.77M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

ExodusPoint Capital Management reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
ExodusPoint Capital Management sold 150,670 Olema Pharmaceuticals shares in Q1 2026, an estimated $3.77M.
ExodusPoint Capital Management first reported a position in Olema Pharmaceuticals in Q4 2020 and held it in 6 quarters.
ExodusPoint Capital Management's Olema Pharmaceuticals position peaked at $3.77M in Q4 2025.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.